Two Sigma Advisers’s Calithera Biosciences CALA Stock Holding History
Bought
Maintained
Sold
Other funds holding CALA
Two Sigma Advisers's CALA Position: Q2 2022 in Review
Two Sigma Advisers sold out of Calithera Biosciences (CALA) in Q2 2022, closing a stake of 62,125 shares — an estimated $502K sold.
Two Sigma Advisers first reported a position in CALA in Q4 2017 and held it in 15 quarters. The position peaked at $2.16M in Q2 2020. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.
- Two Sigma Advisers reported no remaining Calithera Biosciences position as of Q2 2022 after selling out during the quarter.
- Two Sigma Advisers sold 62,125 Calithera Biosciences shares in Q2 2022, an estimated $502K.
- Two Sigma Advisers first reported a position in Calithera Biosciences in Q4 2017 and held it in 15 quarters.
- Two Sigma Advisers's Calithera Biosciences position peaked at $2.16M in Q2 2020.
- 28 funds tracked by Wall St. Rank held Calithera Biosciences as of Q2 2022.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.